-
AtriCure, Inc. (NASDAQ:ATRC) Q4 2023 Earnings Call Transcript
16 Feb 2024 16:37 GMT
… approvals, clearances, reimbursement and clinical trial outcomes.
AtriCure’s results may differ materially … Afib diagnosis through our LeAAPS clinical trial. The LeAAPS trial seeks … and expansion of our LeAAPS clinical trial and multiple product development …
-
AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results
15 Feb 2024 21:10 GMT
… driven by investments in clinical trials and product development initiatives outpacing … following the presentation.
About AtriCure
AtriCure, Inc. provides innovative technologies … Financial Measures
To supplement AtriCure’s condensed consolidated financial …
-
Head-To-Head Comparison: AtriCure (NASDAQ:ATRC) and NovoCure (NASDAQ:NVCR)
10 Dec 2023 17:24 GMT
… NovoCure is more favorable than AtriCure.
Summary
AtriCure beats NovoCure on 10 … also has ongoing or completed clinical trials investigating TTFields in brain metastases … Helier, Jersey.
About AtriCure
(Get Free Report)
AtriCure, Inc. develops, manufactures …
-
AtriCure Releases 2023 ESG Report
14 Nov 2023 13:21 GMT
… amp;I) practices.
Launching key clinical trials and research studies focused on … employee learning and development. AtriCure created unique opportunities for educational … to view the report.
About AtriCure
AtriCure, Inc. provides innovative technologies for …
-
AtriCure, Inc. (NASDAQ:ATRC) Q3 2023 Earnings Call Transcript
02 Nov 2023 19:21 GMT
… Call Transcript November 1, 2023
AtriCure, Inc. beats earnings expectations. … approvals, clearances, reimbursement and clinical trial outcomes.
A healthcare professional examining … materially from those projected. AtriCure undertakes no obligation to publicly …
-
AtriCure Announces the First Patient Treated in the LeAAPS™ Clinical Trial
31 Jan 2023 13:10 GMT
… , investigational device exemption (IDE) clinical trial to evaluate the safety and … atrial fibrillation and stroke.”
About AtriCure
AtriCure, Inc. provides innovative technologies … of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation …
-
AtriCure, Inc. (NASDAQ:ATRC) Q2 2023 Earnings Call Transcript
28 Jul 2023 18:45 GMT
… approvals, clearances, reimbursement and clinical trial outcomes. AtriCure’s results may differ materially … devices through the groundbreaking LeAAPS clinical trial. With two-thirds of the … investment in the HEAL-IST clinical trial in a dedicated IST clamp …
-
AtriCure Announces the First Patient Treated in the HEAL-IST Clinical Trial
07 Jun 2022 12:33 GMT
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced that the first patient was treated in the …
-
AtriCure, Inc. (NASDAQ:ATRC) Q4 2022 Earnings Call Transcript
24 Feb 2023 00:26 GMT
… approvals, clearances, reimbursement and clinical trial outcomes. AtriCure’s results may differ … contemplates heavy enrollment within our clinical trials as more sites activate … the lens of clinical trial — real expansion of the clinical trials and a …
-
AtriCure treats first patient in stroke prevention trial
01 Feb 2023 03:04 GMT
… AtriClip. Mason, Ohio-based AtriCure designed AtriClip for the … make it the largest randomized clinical trial for surgical LAA exclusion, … , president and CEO of AtriCure.
Carrel added that the … also allows AtriCure to expand its markets.
AtriCure plans to …